Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,685 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,116
Recruiting: 10,894
Ph III recruiting: 1,280
Growth YoY: +12%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,163)

clinicaltrialsPublishedShowing 90,451–90,500 of 90,685 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00197431	Pharmacokinetic and Pharmacodynamic Study of S-1 in Patients With Digestive Organ Cancer	unknown	Phase 2	—	Hamamatsu UniversityOTHER	1	Mar 22, 2006	clinicaltrials
NCT00305149	Risk Adapted Beacopp Regimen for Standard and High Risk Hodgkin Lymphoma	completed	N/A	130	Rambam Health Care CampusOTHER	1	Mar 21, 2006	clinicaltrials
NCT00304694